Anal cancer metastatic

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Checkpoint inhibitor (PD-L1) 1 substance
Unknown / small molecule 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Oncolytics Biotech Inc. Commercial
    ATEZOLIZUMAB; PELAREOREP
    2024-515936-62-00 1 country 2024 n=102
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Oncolytics Biotech Inc. Commercial 1 Phase I/II 0
New trials by year
2024
1
← All indication landscapes